Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Amoxicillin Administration Regimen and Resistance Mechanisms of Staphylococcus aureus Established in Tissue Cage Infection Model.

Yao Q, Gao L, Xu T, Chen Y, Yang X, Han M, He X, Li C, Zhou R, Yang Y.

Front Microbiol. 2019 Jul 22;10:1638. doi: 10.3389/fmicb.2019.01638. eCollection 2019.

2.

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.

Xiong M, Wu X, Ye X, Zhang L, Zeng S, Huang Z, Wu Y, Sun J, Ding H.

Front Microbiol. 2016 Jun 7;7:874. doi: 10.3389/fmicb.2016.00874. eCollection 2016.

3.

Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.

Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP.

Antimicrob Agents Chemother. 1990 Dec;34(12):2312-7.

4.

Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.

Boak LM, Li J, Rayner CR, Nation RL.

Antimicrob Agents Chemother. 2007 Apr;51(4):1287-92. Epub 2007 Jan 22.

6.

Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus.

Campion JJ, Chung P, McNamara PJ, Titlow WB, Evans ME.

Antimicrob Agents Chemother. 2005 Jun;49(6):2189-99.

7.

In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model.

Andes D, Craig W, Nielsen LA, Kristensen HH.

Antimicrob Agents Chemother. 2009 Jul;53(7):3003-9. doi: 10.1128/AAC.01584-08. Epub 2009 May 4.

9.

Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.

Andes D, Craig WA.

Antimicrob Agents Chemother. 2003 Dec;47(12):3935-41.

10.

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.

Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH.

J Antimicrob Chemother. 2006 Dec;58(6):1185-92. Epub 2006 Oct 5.

PMID:
17028094
12.

In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.

Firsov AA, Golikova MV, Strukova EN, Portnoy YA, Romanov AV, Edelstein MV, Zinner SH.

Antimicrob Agents Chemother. 2015 Feb;59(2):1014-9. doi: 10.1128/AAC.04214-14. Epub 2014 Dec 1.

13.

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2010 May;35(5):451-6. doi: 10.1016/j.ijantimicag.2009.12.022. Epub 2010 Feb 24.

PMID:
20185277
14.

Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

Campion JJ, McNamara PJ, Evans ME.

Antimicrob Agents Chemother. 2004 Dec;48(12):4733-44.

15.

Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.

Laohavaleeson S, Tessier PR, Nicolau DP.

Antimicrob Agents Chemother. 2008 Jul;52(7):2389-94. doi: 10.1128/AAC.01422-07. Epub 2008 Apr 14.

16.

Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.

Kesteman AS, Ferran AA, Perrin-Guyomard A, Laurentie M, Sanders P, Toutain PL, Bousquet-Mélou A.

Antimicrob Agents Chemother. 2009 Nov;53(11):4740-8. doi: 10.1128/AAC.00608-09. Epub 2009 Sep 8.

17.
18.

Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.

Worlitzsch D, Kaygin H, Steinhuber A, Dalhoff A, Botzenhart K, Döring G.

Antimicrob Agents Chemother. 2001 Jan;45(1):196-202.

19.

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Andes D, Craig WA.

Antimicrob Agents Chemother. 2006 Apr;50(4):1376-83. Erratum in: Antimicrob Agents Chemother. 2014 Apr;58(4):2489. Dosage error in article text.

20.

Supplemental Content

Support Center